# Cue Biopharma, Inc. (CUE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CUE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 13.56M | $ -158.25M | $ -40.07M | $ 8.81M | $ 2.31M |
| 2025 | $ 28.12M | $ -27.24M | $ -22.39M | $ 4.20M | $ 26.43M |
| 2024 | $ 9.76M | $ -42.75M | $ -38.25M | $ 8.88M | $ 17.50M |
| 2023 | $ 5.94M | $ -54.86M | $ -43.21M | $ 14.70M | $ 37.09M |
| 2022 | $ 1.39M | $ -59.22M | $ -46.89M | $ 19.32M | $ 65.68M |
| 2021 | $ 17.76M | $ -52.49M | $ -47.25M | $ 12.02M | $ 65.49M |
| 2020 | $ 4.02M | $ -57.05M | $ 137.02M | $ 7.15M | $ 78.91M |
| 2019 | $ 4.46M | $ -47.37M | $ -39.81M | $ 5.80M | $ 54.58M |
| 2018 | $ 1.26M | $ -51.51M | $ -37.33M | N/A | $ 33.97M |
| 2017 | $ 0 | $ -31.30M | $ -18.05M | $ 2.50M | $ 61.61M |
| 2016 | $ 0 | $ -10.54M | $ -8.92M | $ 0 | $ 15.17M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 3.81 |
| Liabilities / Eq | 12.29 |
| Current Ratio | 1.25 |

## Other views

- [Metrics](https://sponda.capital/en/CUE.md)
- [Charts](https://sponda.capital/en/CUE/charts.md)
- [Compare](https://sponda.capital/en/CUE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.